Telomere length is shorter in affected members of families with familial nonmedullary thyroid cancer

Thyroid

Volumn 23, Issue 3, 2013, Pages 301-307

  He, Mei ^a   Bian, Brent ^a   Gesuwan, Krisana ^a   Gulati, Neelam ^a   Zhang, Lisa ^a   Nilubol, Naris ^a   Kebebew, Electron ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL NONMEDULLARY THYROID CANCER; FEMALE; GENE; GENE DOSAGE; GENE EXPRESSION; HUMAN; LYMPHOCYTE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTECTION OF TELOMERE 1 GENE; REPRESSOR ACTIVATOR PROTEIN 1 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELOMERASE REVERSE TRANSCRIPTASE GENE; TELOMERE HOMEOSTASIS; TELOMERIC REPEAT BINDING FACTOR 1 GENE; TELOMERIC REPEAT BINDING FACTOR 2 GENE; THYROID CANCER; TRF1 INTERACTING NUCLEAR FACTOR 2 GENE; TRIPEPTIDYL PEPTIDASE 1 GENE;

ADULT; CARCINOMA; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PEDIGREE; POLYMERASE CHAIN REACTION; QUESTIONNAIRES; RNA, MESSENGER; TELOMERASE; TELOMERE; TELOMERE-BINDING PROTEINS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84874883682     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0270     Document Type: Article

References (26)

1. Chen AY, Jemal A, Ward EM 2009 Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 115:3801-3807
2. Loh KC 1997 Familial nonmedullary thyroid carcinoma: A meta-review of case series. Thyroid 7:107-113
3. Stoffer SS, Van Dyke DL, Bach JV, Szpunar W, Weiss L 1986 Familial papillary carcinoma of the thyroid. Am J Med Genet 25:775-782
4. Moses W, Weng J, Kebebew E 2011 Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. Thyroid 21:367-371
5. Vriens MR, Suh I, Moses W, Kebebew E 2009 Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer. Thyroid 19:1343-1349
6. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH 1994 Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600-1608
7. Hemminki K, Eng C, Chen B 2005 Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab 90:5747-5753
8. Capezzone M, Marchisotta S, Cantara S, Busonero G, Brilli L, Pazaitou-Panayiotou K, Carli AF, Caruso G, Toti P, Capitani S, Pammolli A, Pacini F 2008 Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr Relat Cancer 15:1075-1081
9. Blasco MA 2005 Telomeres and human disease: Ageing, cancer and beyond. Nat Rev Genet 6:611-622
10. De Lange T 2005 Telomere-related genome instability in cancer. Cold Spring Harb Symp Quant Biol 70:197-204
11. Hockemeyer D, Daniels JP, Takai H, de Lange T 2006 Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres. Cell 126:63-77
12. Wu L, Multani AS, He H, Cosme-Blanco W, Deng Y, Deng JM, Bachilo O, Pathak S, Tahara H, Bailey SM, Deng Y, Behringer RR, Chang S 2006 Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell 126:49-62
13. He H, Multani AS, Cosme-Blanco W, Tahara H, Ma J, Pathak S, Deng Y, Chang S 2006 POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination. EMBO J 25:5180-5190
14. Martinez P, Blasco MA 2011 Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer 11:161-176
15. Masutomi K, Hahn WC 2003 Telomerase and tumorigenesis. Cancer Lett 194:163-172
16. Ma H, Zhou Z, Wei S, Liu Z, Pooley KA, Dunning AM, Svenson U, Roos G, Hosgood HD 3rd, Shen M, Wei Q 2011 Shortened telomere length is associated with increased risk of cancer: A meta-analysis. PLoS One 6:e20466
17. Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I 2004 Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet 36:447-449
18. CapezzoneM, Cantara S,Marchisotta S, Filetti S,De SantiMM, Rossi B, Ronga G, Durante C, Pacini F 2008 Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients. J Clin EndocrinolMetab 93:3950-3957
19. Granger MP, Wright WE, Shay JW 2002 Telomerase in cancer and aging. Crit Rev Oncol Hematol 41:29-40
20. Capezzone M, Cantara S, Marchisotta S, Busonero G, Formichi C, Benigni M, Capuano S, Toti P, Pazaitou-Panayiotou K, Caruso G, Carli AF, Palummo N, Pacini F 2011 Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer. J Clin Endocrinol Metab 96:E1852-E1856
21. Jendrzejewski J, Tomsic J, Lozanski G, Labanowska J, He H, Liyanarachchi S, Nagy R, Ringel MD, Kloos RT, Heerema NA, de la Chapelle A 2011 Telomere length and telomerase reverse transcriptase gene copy number in patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 96:E1876-E1880
22. Malchoff CD, Malchoff DM 2006 Familial nonmedullary thyroid carcinoma. Cancer Control 13:106-110
23. Helgason A, Nicholson G, Stefansson K, Donnelly P 2003A reassessment of genetic diversity in Icelanders: Strong evidence from multiple loci for relative homogeneity caused by genetic drift. Ann Hum Genet 67:281-297
24. Chiang YJ, Calado RT, Hathcock KS, Lansdorp PM, Young NS, Hodes RJ 2010 Telomere length is inherited with resetting of the telomere set-point. Proc Natl Acad Sci USA 107:10148-10153
25. Liu L, Trimarchi JR, Navarro P, Blasco MA, Keefe DL 2003 Oxidative stress contributes to arsenic-induced telomere attrition, chromosome instability, and apoptosis. J Biol Chem 278:31998-32004
26. Schoeftner S, Blasco MA 2009A 'higher order' of telomere regulation: Telomere heterochromatin and telomeric RNAs. EMBO J 28:2323-2336